However, using particular inhibitors and/or medicines that affect epigenetics to manipulate the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) (JAK/STAT) signaling system could be a promising therapeutic option for RA [129]. The gene discussed is SOAT1; the disease is rheumatoid arthritis.